This is an old revision of this page, as edited by Bill37212 (talk | contribs) at 19:37, 4 January 2006 (disambiguation link repair (You can help!)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:37, 4 January 2006 by Bill37212 (talk | contribs) (disambiguation link repair (You can help!))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
A tetracyclic antidepressant is an antidepressant drug from the tetracyclic drug group.
The name tetracyclic is derived from the drug's molecular structure which consists of four ring like structures (compare tricyclic antidepressant).
Maprotiline, trade named Ludiomil®, and Mirtazapine, trade named Remeron® in the USA and Zispin® in Europe, are the only two drugs from this group widely used for the treatment of clinical depression. The tetracyclic antidepressant Mianserin was previously available internationally, however in most markets it has been phased out in favor of Mirtazepine.
Research on other tetracyclic antidepressant compounds (for example setiptiline) have been reported in the scientific literature. These other tetracyclic antidepressants are not publicly available.
There are also several chemically unrelated tetracyclic antibiotics based on Tetracycline.
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |